A Retrospective Study of the Impact of 21-Gene Recurrence Score Assay on Treatment Choice in Node Positive Micrometastatic Breast Cancer

Author： Frazier Thomas G.   Fox Kevin R.   Smith J. Stanley   Laronga Christine   McSwain Anita   Paul Devchand   Schultz Michael   Stilwill Joseph   Teal Christine   Weisberg Tracey   Vacchino Judith F.   Sing Amy P.   Cherepanov Dasha   Hsiao Wendy   Chang Eunice   Broder Michael S.  

Publisher： MDPI

E-ISSN： 1424-8247|8|1|107-122

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.8, Iss.1, 2015-03, pp. : 107-122

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score

By Ahn Sung Gwe   Lee Hak Min   Lee Hak Woo   Lee Seung Ah   Lee Se-Ra   Leem Sun-Hee   Jeong Joon   Chu In-Sun  

International Journal of Molecular Sciences, Vol. 14, Iss. 12, 2013-12 ,pp. : 23685-23699

MDPI

Access to resources Recommend Favorite

Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling

By Villegas Victoria E.   Rondón-Lagos Milena   Annaratone Laura   Castellano Isabella   Grismaldo Adriana   Sapino Anna   Zaphiropoulos Peter G.  

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-02 ,pp. : 308-308

MDPI

Access to resources Recommend Favorite

An Institutional Retrospective Analysis of 93 Patients with Brain Metastases from Breast Cancer: Treatment Outcomes, Diagnosis-Specific Prognostic Factors

By Antoni Delphine   Clavier Jean-Baptiste   Pop Marius   Benoît Céline   Lefebvre François   Noël Georges  

International Journal of Molecular Sciences, Vol. 13, Iss. 12, 2012-12 ,pp. : 16489-16499

MDPI

Access to resources Recommend Favorite

Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer

By Buchegger Kurt   Riquelme Ismael   Viscarra Tamara   Ili Carmen   Brebi Priscilla   Huang Tim Hui-Ming   Roa Juan Carlos  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1525-1525

MDPI

Access to resources Recommend Favorite

Discovery of a Potential HER2 Inhibitor from Natural Products for the Treatment of HER2-Positive Breast Cancer

By Li Jianzong   Wang Haiyang   Li Junjie   Bao Jinku   Wu Chuanfang  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1055-1055

MDPI

Access to resources Recommend Favorite